Kodiak Sciences (KOD) Shares Outstanding (Weighted Average) (2016 - 2026)

Kodiak Sciences (KOD) reported Shares Outstanding (Weighted Average) of $61.9 million for Q1 2026, up 17.28% on a YoY basis from $52.7 million in Q1 2025, and up 16.26% quarter-over-quarter from $53.2 million in Q4 2025.

Kodiak Sciences (KOD) Shares Outstanding (Weighted Average) (2016 - 2026) Analysis & Trends

Kodiak Sciences has reported Shares Outstanding (Weighted Average) for 11 years, with the latest figure at $61.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 17.28% year-over-year to $61.9 million; the trailing twelve-month figure through Mar 2026 stood at $61.9 million (up 17.28% YoY), and the FY2025 full-year result was $53.2 million, up 1.19% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $61.9 million, up from $53.2 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $61.9 million in Q1 2026, with the low at $52.2 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $53.1 million across 5 years, with a median of $52.5 million in 2024.
  • Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) climbed 0.2% — and 2026, when it rose 17.28%.
  • Kodiak Sciences' Shares Outstanding (Weighted Average) stood at $52.2 million in 2022, then grew by 0.32% to $52.4 million in 2023, then gained by 0.32% to $52.6 million in 2024, then increased by 1.19% to $53.2 million in 2025, then grew by 16.26% to $61.9 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $61.9 million (Q1 2026), $53.2 million (Q4 2025), and $52.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 185,491.37 Bn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 4,489.46 Bn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 100.00 Bn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 118.76 Bn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 417.01 Bn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 254.10 Mn
9 Abivax 95.45 Bn 95.45 Bn - 928.40 Mn
10 Kodiak Sciences 1.92 Bn 1.92 Bn - 61.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 61.86 Mn
Dec 31, 2025 53.21 Mn
Sep 30, 2025 52.80 Mn
Jun 30, 2025 52.76 Mn
Mar 31, 2025 52.75 Mn
Dec 31, 2024 52.58 Mn
Sep 30, 2024 52.56 Mn
Jun 30, 2024 52.53 Mn
Mar 31, 2024 52.51 Mn
Dec 31, 2023 52.41 Mn
Sep 30, 2023 52.39 Mn
Jun 30, 2023 52.38 Mn
Mar 31, 2023 52.34 Mn
Dec 31, 2022 52.25 Mn
Sep 30, 2022 52.29 Mn
Jun 30, 2022 52.22 Mn
Mar 31, 2022 52.17 Mn
Dec 31, 2021 51.79 Mn
Sep 30, 2021 51.88 Mn
Jun 30, 2021 51.57 Mn